AI research project aims to improve drug-resistant epilepsy outcomes
A new UK project will use anonymised healthcare data and AI to better predict drug resistance in epilepsy.
A research collaboration between Swansea University and King’s College London has secured a prestigious Medical Research Council project grant to tackle drug-resistant epilepsy.
The project brings together clinicians, data scientists, AI specialists, and individuals with lived experience from the Epilepsy Research Institute’s Shape Network to advance understanding and treatment of the condition.
Drug-resistant epilepsy affects around 30% of the 600,000 people living with epilepsy in the UK, leading to ongoing seizures, memory issues, and mood disorders.
Researchers will use advanced natural language processing, AI, and anonymised healthcare data to better predict who will develop resistance to medications and how treatments can be prioritised.
Project lead Dr Owen Pickrell from Swansea University highlighted the unique opportunity to combine real-world clinical data with cutting-edge AI to benefit people living with the condition.
Annee Amjad from the Epilepsy Research Institute also welcomed the project, noting that it addresses several of the UK’s top research priorities for epilepsy.
Would you like to learn more about AI, tech and digital diplomacy? If so, ask our Diplo chatbot!
About author
DW Team
The GIP Digital Watch Observatory team, consisting of over 30 digital policy experts from around the world, excels in the fields of research and analysis on digital policy issues. The team is backed by the creative prowess of Creative Lab Diplo and the technical expertise of the Diplo tech team.
